Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis

Overview of attention for article published in Journal for Immunotherapy of Cancer, December 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

blogs: 1 blog

twitter: 7 X users

Citations

dimensions_citation: 139 Dimensions

Readers on

mendeley: 109 Mendeley

Summary Blogs X Dimensions citations

So far, Altmetric has seen 9 X posts from 7 X users, with an upper bound of 22,388 followers.

#JITC Review: Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis https://t.co/zdehQVk93z https://t.co/XhVVzykXXN

04 Jan 2020

Reply Repost Favourite

RT @jitcancer: New #JITC Review: Incidence rates of immune-related adverse events and their correlation with response in advanced solid tum…

27 Dec 2019

Reply Repost Favourite

New #JITC Review: Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis https://t.co/zdehQVk93z https://t.co/nNzcxN5P1T

27 Dec 2019

Reply Repost Favourite

RT @nanudasmd: The narrative between IRAEs and checkpoint inhibitor efficacy continues to evolve. Teasing out specific sites of IRAEs and b…

11 Dec 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.